BioCentury
ARTICLE | Clinical News

AlphaRx, Gaia BioPharma preclinical data

July 13, 2009 7:00 AM UTC

In rats, GAI-122 ameliorated learning and memory disturbances produced by cerebral embolization, cerebral ischemia or lesions in the basal forebrain. Gaia has an exclusive license to GAI-122 from Alph...